HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Lipodystrophy

A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy.
Also Known As:
Lipodystrophies
Networked: 1655 relevant articles (75 outcomes, 170 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Insulin Resistance
2. HIV Infections (HIV Infection)
3. Dyslipidemias (Dyslipidemia)
4. Acquired Immunodeficiency Syndrome (AIDS)
5. Hyperinsulinism (Hyperinsulinemia)

Experts

1. Domingo, Pere: 32 articles (01/2015 - 12/2002)
2. Gorden, Phillip: 27 articles (01/2016 - 02/2002)
3. Garg, Abhimanyu: 27 articles (10/2015 - 02/2002)
4. Capeau, Jacqueline: 24 articles (01/2013 - 05/2002)
5. O'Rahilly, Stephen: 18 articles (01/2015 - 04/2003)
6. Mantzoros, Christos S: 16 articles (10/2015 - 02/2003)
7. Andersen, Ove: 16 articles (03/2015 - 10/2003)
8. Villarroya, Francesc: 16 articles (01/2015 - 02/2005)
9. Martínez, Esteban: 16 articles (01/2015 - 12/2002)
10. Vigouroux, Corinne: 16 articles (01/2013 - 01/2003)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Lipodystrophy:
1. LeptinIBA
2. Insulin (Novolin)FDA Link
3. Glucose (Dextrose)FDA LinkGeneric
4. tesamorelinFDA Link
5. Protease Inhibitors (Protease Inhibitor)IBA
6. Mitochondrial DNA (mtDNA)IBA
7. Nevirapine (Viramune)FDA Link
8. Ritonavir (Norvir)FDA Link
9. LipidsIBA
10. ThymidineIBA

Therapies and Procedures

1. Highly Active Antiretroviral Therapy (HAART)
2. Lipectomy (Liposuction)
3. Caloric Restriction
4. Drug Therapy (Chemotherapy)
5. Meditation